GlassScriptPhysician profile
Golnaz Naghdi
NPI 1730385683
$690.84
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50.00 · 2020: $37.06 · 2022: $174 · 2023: $192 · 2024: $238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $430.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $429.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $253.89 | 2022-2024 | Itero Element 5d, Invisalign |
| Revance Therapeutics, INC. | $152.05 | 2024 | Daxxify |
| Nobel Biocare USA | $119.50 | 2023 | Nobelactive |
| Osteoready LLC | $50.00 | 2019 | |
| Biohorizons Implant Systems INC. | $47.92 | 2023-2024 | Biohorizons |
| Dentsply Sirona INC | $40.21 | 2020-2024 | Astra Tech Implant System |
| Orapharma, A Division of Bausch Health US, LLC | $15.77 | 2022 | |
| Philips North America LLC | $11.50 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Golnaz Naghdi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.